Sareum (SAR) Competitors GBX 17.27 -0.23 (-1.31%) As of 11:18 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SAR vs. PHD, NMT, IGR, FEN, CGO, TSI, MYN, IDE, EVG, and PCFShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include Proactis (PHD), Neometals (NMT), IG Design Group (IGR), Frenkel Topping Group (FEN), Contango (CGO), Two Shields Investments Plc (TSI.L) (TSI), Mayan Energy (MYN), IDE Group (IDE), Evgen Pharma (EVG), and PCF Group (PCF). These companies are all part of the "financial services" industry. Sareum vs. Proactis Neometals IG Design Group Frenkel Topping Group Contango Two Shields Investments Plc (TSI.L) Mayan Energy IDE Group Evgen Pharma PCF Group Sareum (LON:SAR) and Proactis (LON:PHD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings. Does the MarketBeat Community believe in SAR or PHD? Proactis received 91 more outperform votes than Sareum when rated by MarketBeat users. However, 66.13% of users gave Sareum an outperform vote while only 55.10% of users gave Proactis an outperform vote. CompanyUnderperformOutperformSareumOutperform Votes8266.13% Underperform Votes4233.87% ProactisOutperform Votes17355.10% Underperform Votes14144.90% Which has preferable valuation and earnings, SAR or PHD? Proactis has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than Proactis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSareumN/AN/A-£5.28M-£4.22-4.09Proactis£48.90M0.00N/A-£20.70N/A Does the media favor SAR or PHD? In the previous week, Sareum had 2 more articles in the media than Proactis. MarketBeat recorded 2 mentions for Sareum and 0 mentions for Proactis. Proactis' average media sentiment score of 0.00 beat Sareum's score of -0.32 indicating that Proactis is being referred to more favorably in the news media. Company Overall Sentiment Sareum Neutral Proactis Neutral Is SAR or PHD more profitable? Proactis' return on equity of 0.00% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets SareumN/A -270.25% -113.80% Proactis N/A N/A N/A SummaryProactis beats Sareum on 6 of the 9 factors compared between the two stocks. Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£21.58M£123.10M£5.52B£2.55BDividend Yield1.10%3.69%5.11%4.97%P/E Ratio-4.093.1822.34132.08Price / SalesN/A4,153.47391.19232,628.55Price / Cash11.3213.0238.1828.14Price / Book6.6233.196.674.51Net Income-£5.28M-£90.45M£3.22B£5.85B7 Day Performance7.94%4.05%1.93%2.71%1 Month Performance28.50%1.04%-1.23%8.64%1 Year Performance-28.78%92.82%17.23%110.50% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 17.27-1.3%N/A-33.3%£21.58MN/A-4.093,211Gap DownPHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516NMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/AIGRIG Design Group3.4034 of 5 starsGBX 49.31+0.6%GBX 270+447.6%-59.2%£48.39M£655.48M1.673,092Analyst ForecastNews CoverageGap DownFENFrenkel Topping GroupN/AGBX 32.90+1.2%N/A-28.6%£40.31M£34.56M38.33307Earnings ReportPositive NewsGap UpCGOContangoN/AGBX 0.90+9.1%N/A-12.4%£6.51MN/A-90.002,219TSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053MYNMayan EnergyN/AN/AN/AN/A£5.28M£-3,000.00-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010PCFPCF GroupN/AN/AN/AN/A£3.17M£19.54M-0.79125Gap DownHigh Trading Volume Related Companies and Tools Related Companies Proactis Competitors Neometals Competitors IG Design Group Competitors Frenkel Topping Group Competitors Contango Competitors Two Shields Investments Plc (TSI.L) Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors PCF Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SAR) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SAR Stock Free SAR Stock Alerts